Growth Metrics

Bio-Techne (TECH) Cash from Operations Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 37.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 16.64%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.60%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 34.32%
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 19.70%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 19.70%
Dec 31, 2025 8.58%
Sep 30, 2025 -21.06%
Jun 30, 2025 -1.49%
Mar 31, 2025 -17.46%
Dec 31, 2024 -5.83%
Sep 30, 2024 9.67%
Jun 30, 2024 -14.79%
Mar 31, 2024 2.65%
Dec 31, 2023 -2.35%
Sep 30, 2023 -3.46%
Jun 30, 2023 23.02%
Mar 31, 2023 0.71%
Dec 31, 2022 -2.94%
Sep 30, 2022 11.42%
Jun 30, 2022 22.45%
Mar 31, 2022 22.62%
Dec 31, 2021 29.44%
Sep 30, 2021 7.08%
Jun 30, 2021 23.46%
Mar 31, 2021 51.22%
Dec 31, 2020 31.58%
Sep 30, 2020 13.88%
Jun 30, 2020 -4.14%
Mar 31, 2020 25.51%
Dec 31, 2019 19.15%
Sep 30, 2019 15.22%
Jun 30, 2019 15.14%
Mar 31, 2019 2.22%
Dec 31, 2018 6.51%
Sep 30, 2018 7.41%
Jun 30, 2018 20.41%
Mar 31, 2018 -11.06%
Dec 31, 2017 3.13%
Sep 30, 2017 7.76%
Jun 30, 2017 10.27%
Mar 31, 2017 -10.53%
Dec 31, 2016 9.95%
Sep 30, 2016 -6.66%
Jun 30, 2016 6.92%
Mar 31, 2016 3.99%
Dec 31, 2015 7.20%
Sep 30, 2015 2.85%
Jun 30, 2015 -0.24%
Mar 31, 2015 -3.70%
Dec 31, 2014 20.46%
Sep 30, 2014 1.23%
Jun 30, 2014 3.03%
Mar 31, 2014 2.56%
Dec 31, 2013 2.10%
Sep 30, 2013 2.00%
Jun 30, 2013 -1.92%
Mar 31, 2013 12.46%
Dec 31, 2012 3.48%
Sep 30, 2012 1.45%